Importantly, the results of CHIP-qPCR assays certify that KDM4D interacts with the JAG1 promoter, which means KDM4D can transcriptionally activate JAG1 and promote ccRCC angiogenesis and development. The gene discussed is KDM4D; the disease is nonpapillary renal cell carcinoma.